Repurposing amniotic membrane as a native scaffold for cancer cell invasion studies
Open Access
- 17 September 2025
- journal article
- Published by Open Exploration Publishing in Exploration of biomat-x
- Vol. 2, 101346
Abstract
Modeling cancer cell invasion requires physiologically relevant systems, yet traditional 2D/3D assays and animal models fail to capture the biochemical and mechanical complexity of the human extracellular matrix (ECM). The human amniotic membrane (AM) is a clinically approved, abundant, and immunologically privileged tissue with a rich ECM composition and favorable mechanical properties. Despite its extensive use in regenerative medicine, its potential as a cancer invasion scaffold remains underexplored. We propose repurposing decellularized AM (dAM) as a human-derived ECM platform to study tumor invasion. dAM retains structural proteins, growth factor reservoirs, and stiffness gradients that influence epithelial-to-mesenchymal transition (EMT) and invasion pathways. Compared with conventional matrices, it offers improved biochemical fidelity and compatibility with patient-derived organoids. Key challenges, including donor variability, decellularization optimization, and reproducibility, are also addressed. dAM provides a non-invasive, scalable, and physiologically relevant tool for cancer invasion assays, drug screening, and patient-specific models. Its integration into oncology research may enhance translational relevance and accelerate personalized medicine.Keywords
This publication has 33 references indexed in Scilit:
- Bovine amniotic membrane with antioxidant and anti-inflammatory properties for the repair of alkali-burned corneasActa Biomaterialia, 2025
- Amniotic Membrane‐Derived Extracellular Matrix for Developing a Cost‐Effective Xenofree Hepatocellular Carcinoma Organoid ModelJournal of Biomedical Materials Research Part A, 2025
- Human amniotic membrane scaffold enhances adipose mesenchymal stromal cell mitochondrial bioenergetics promoting their regenerative capacitiesMolecular and Cellular Biochemistry, 2024
- Assessment of the proteome profile of decellularized human amniotic membrane and its biocompatibility with umbilical cord‐derived mesenchymal stem cellsJournal of Biomedical Materials Research Part A, 2024
- Application of the Human Amniotic Membrane as an Adjuvant Therapy for the Treatment of Hepatocellular Carcinoma2023
- Comparison of the effects of preservation methods on structural, biological, and mechanical properties of the human amniotic membrane for medical applicationsCell and Tissue Banking, 2023
- A tri-layer decellularized, dehydrated human amniotic membrane scaffold supports the cellular functions of human tenocytes in vitroJournal of Materials Science: Materials in Medicine, 2023
- The developments in amniotic membrane transplantation in glaucoma and vitreoretinal proceduresInternational Ophthalmology, 2023
- Transwell® Invasion Assays2011
- Tail Vein Assay of Cancer MetastasisCurrent Protocols in Cell Biology, 2001